Suppr超能文献

多能干细胞来源的人类多细胞肝类器官的生成。

Generation of multi-cellular human liver organoids from pluripotent stem cells.

机构信息

Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.

Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Center for Stem Cell and Organoid Medicine (CuSTOM), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States; Institute of Research, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

出版信息

Methods Cell Biol. 2020;159:47-68. doi: 10.1016/bs.mcb.2020.03.009. Epub 2020 May 22.

Abstract

A growing number of in vitro hepatic models exist to study human genetics, liver biology, disease modeling and drug development and range from 2D hepatocytes to 3D multi-cellular tissues that are derived from human stem cells. However, stem cell-based models generally suffer from batch-, clone- and donor-dependent variability, hindering broader usage in diverse biomedical applications. To circumvent this challenge, we herein describe a reproducible protocol to generate human liver organoids in 20-25 days derived from pluripotent stem cells (PSCs). These organoids are intra-luminally polarized to form canalicular structures and are comprised of mainly hepatic epithelial cells, co-differentiated with stellate-like and hepatic macrophage-like cells that enables hepatic inflammatory disease modeling in vitro. These multi-lineage liver organoids express hepatocyte genes, secrete albumin and have vital metabolic functions. This protocol utilizes PSC derived 3D human liver organoids as a renewable, reproducible and personalized cell source, thus facilitating disease modeling and mechanistic studies with a future goal of developing novel therapeutics against currently intractable diseases.

摘要

越来越多的体外肝脏模型被用于研究人类遗传学、肝脏生物学、疾病建模和药物开发,范围从 2D 肝细胞到源自人类干细胞的 3D 多细胞组织。然而,基于干细胞的模型通常存在批次、克隆和供体依赖性变异性,这阻碍了它们在各种生物医学应用中的广泛使用。为了克服这一挑战,我们在此描述了一种在 20-25 天内从多能干细胞 (PSC) 生成人类肝类器官的可重复协议。这些类器官在腔内向极化形成胆小管结构,并主要由肝细胞组成,与星状细胞和肝巨噬细胞样细胞共分化,从而能够在体外进行肝炎症性疾病建模。这些多能性肝类器官表达肝细胞基因,分泌白蛋白,并具有重要的代谢功能。该方案利用 PSC 衍生的 3D 人类肝类器官作为可再生、可重复和个性化的细胞来源,从而促进疾病建模和机制研究,未来的目标是开发针对目前难以治疗疾病的新型治疗方法。

相似文献

1
Generation of multi-cellular human liver organoids from pluripotent stem cells.
Methods Cell Biol. 2020;159:47-68. doi: 10.1016/bs.mcb.2020.03.009. Epub 2020 May 22.
2
Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
J Hepatol. 2019 Nov;71(5):970-985. doi: 10.1016/j.jhep.2019.06.030. Epub 2019 Jul 9.
3
Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells.
Nat Protoc. 2017 Jan;12(1):195-207. doi: 10.1038/nprot.2016.170. Epub 2016 Dec 22.
4
A Scalable Approach for the Generation of Human Pluripotent Stem Cell-Derived Hepatic Organoids with Sensitive Hepatotoxicity Features.
Stem Cells Dev. 2017 Oct 15;26(20):1490-1504. doi: 10.1089/scd.2017.0023. Epub 2017 Aug 24.
5
In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system.
Lab Chip. 2018 Dec 7;18(23):3606-3616. doi: 10.1039/c8lc00869h. Epub 2018 Oct 25.
6
Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids.
Cell Metab. 2019 Aug 6;30(2):374-384.e6. doi: 10.1016/j.cmet.2019.05.007. Epub 2019 May 30.
7
Generation of small intestinal organoids for experimental intestinal physiology.
Methods Cell Biol. 2020;159:143-174. doi: 10.1016/bs.mcb.2020.03.007. Epub 2020 May 4.
8
Engineering human hepato-biliary-pancreatic organoids from pluripotent stem cells.
Nat Protoc. 2021 Feb;16(2):919-936. doi: 10.1038/s41596-020-00441-w. Epub 2021 Jan 11.
9
Stem cell-derived kidney organoids: engineering the vasculature.
Cell Mol Life Sci. 2020 Jun;77(12):2257-2273. doi: 10.1007/s00018-019-03401-0. Epub 2019 Dec 5.
10
Differentiation of Retinal Organoids from Human Pluripotent Stem Cells.
Curr Protoc Stem Cell Biol. 2019 Sep;50(1):e95. doi: 10.1002/cpsc.95.

引用本文的文献

1
Multi-photon, label-free photoacoustic and optical imaging of NADH in brain cells.
Light Sci Appl. 2025 Aug 7;14(1):264. doi: 10.1038/s41377-025-01895-x.
2
Organoid-Guided Precision Medicine: From Bench to Bedside.
MedComm (2020). 2025 May 1;6(5):e70195. doi: 10.1002/mco2.70195. eCollection 2025 May.
3
3D tumor cultures for drug resistance and screening development in clinical applications.
Mol Cancer. 2025 Mar 21;24(1):93. doi: 10.1186/s12943-025-02281-2.
4
Hepatobiliary organoid research: the progress and applications.
Front Pharmacol. 2025 Feb 11;16:1473863. doi: 10.3389/fphar.2025.1473863. eCollection 2025.
5
Organoid, organ-on-a-chip and traditional Chinese medicine.
Chin Med. 2025 Feb 12;20(1):22. doi: 10.1186/s13020-025-01071-8.
6
Modeling metabolic-associated steatohepatitis with human pluripotent stem cell-derived liver organoids.
Hepatol Commun. 2024 Nov 29;8(12). doi: 10.1097/HC9.0000000000000585. eCollection 2024 Dec 1.
7
A High-Throughput Microphysiological Liver Chip System to Model Drug-Induced Liver Injury Using Human Liver Organoids.
Gastro Hep Adv. 2024 Aug 12;3(8):1045-1053. doi: 10.1016/j.gastha.2024.08.004. eCollection 2024.
8
Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids.
JHEP Rep. 2024 Jun 4;6(9):101126. doi: 10.1016/j.jhepr.2024.101126. eCollection 2024 Sep.
10
Regenerative human liver organoids (HLOs) in a pillar/perfusion plate for hepatotoxicity assays.
bioRxiv. 2024 Nov 3:2024.03.25.586638. doi: 10.1101/2024.03.25.586638.

本文引用的文献

2
Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury.
Front Pharmacol. 2019 Sep 24;10:1093. doi: 10.3389/fphar.2019.01093. eCollection 2019.
3
Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling.
Stem Cell Reports. 2019 Oct 8;13(4):627-641. doi: 10.1016/j.stemcr.2019.08.007. Epub 2019 Sep 12.
4
Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
J Hepatol. 2019 Nov;71(5):970-985. doi: 10.1016/j.jhep.2019.06.030. Epub 2019 Jul 9.
5
Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids.
Cell Metab. 2019 Aug 6;30(2):374-384.e6. doi: 10.1016/j.cmet.2019.05.007. Epub 2019 May 30.
6
Organoids of liver diseases: From bench to bedside.
World J Gastroenterol. 2019 Apr 28;25(16):1913-1927. doi: 10.3748/wjg.v25.i16.1913.
7
Generation of hepatobiliary organoids from human induced pluripotent stem cells.
J Hepatol. 2019 Jun;70(6):1145-1158. doi: 10.1016/j.jhep.2018.12.028. Epub 2019 Jan 7.
8
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):145-159. doi: 10.1038/s41575-018-0082-x.
9
Generation of human antral and fundic gastric organoids from pluripotent stem cells.
Nat Protoc. 2019 Jan;14(1):28-50. doi: 10.1038/s41596-018-0080-z.
10
Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases.
Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):920-928. doi: 10.1016/j.bbadis.2018.08.038. Epub 2018 Sep 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验